Literature DB >> 11198634

Life-threatening severe malarial anaemia.

M English1.   

Abstract

Despite our improved understanding of the pathophysiology of severe malaria, major changes in clinical management have not been forthcoming. However, in the case of life-threatening severe malarial anaemia, preliminary evidence suggests that changes in current clinical practice rather than the introduction of novel interventions may improve child survival. This review argues that further research into the clinical physiology of this syndrome is required and could provide compelling evidence for changes in practice particularly with regard to blood transfusion. We focus on the syndrome of severe, symptomatic malarial anaemia associated with a metabolic acidosis which has a high fatality rate. However, it should be remembered that a far greater number of children without signs of life-threatening disease nonetheless experience significant morbidity from severe anaemia. Many of these less-severely ill children may also require blood transfusion. However, the mode and rationale for transfusion in this less-severely ill group is specifically not addressed. Indeed, the arguments presented should not be extrapolated to suggest a uniform approach to transfusion is warranted, the role of blood in the less-critically ill child with severe malaria anaemia being a further area that requires urgent research.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11198634     DOI: 10.1016/s0035-9203(00)90197-4

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  7 in total

1.  Efficacy and Tolerability of Malartin and Sulphadoxine-Pyrimethamine Combination against Uncomplicated Falciparum Malaria in Dibanda, Southwest Cameroon.

Authors:  Helen Kuokuo Kimbi; Mesame Ntoko; Nelson N Ntonifor; Emmaculate Lum; Anna L Njunda; Peter Nde Fon
Journal:  J Trop Med       Date:  2012-02-29

2.  Impact of inconsistent policies for transfusion-transmitted malaria on clinical practice in Ghana.

Authors:  Alex K Owusu-Ofori; Imelda Bates
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

3.  Therapeutic efficacy and effects of artemisinin-based combination treatments on uncomplicated Plasmodium falciparum malaria -associated anaemia in Nigerian children during seven years of adoption as first-line treatments.

Authors:  Akintunde Sowunmi; Kazeem Akano; Godwin Ntadom; Adejumoke I Ayede; Folasade O Ibironke; Temitope Aderoyeje; Elsie O Adewoye; Bayo Fatunmbi; Stephen Oguche; Henrietta U Okafor; Ismaila Watila; Martin Meremikwu; Philip Agomo; William Ogala; Chimere Agomo; Onikepe A Folarin; Grace O Gbotosho; Christian T Happi
Journal:  Infect Dis Poverty       Date:  2017-02-07       Impact factor: 4.520

4.  Prevalence of anemia and associated factors in children living in urban and rural settings from Bata District, Equatorial Guinea, 2013.

Authors:  Policarpo Ncogo; Maria Romay-Barja; Agustin Benito; Pilar Aparicio; Gloria Nseng; Pedro Berzosa; Maria A Santana-Morales; Matilde Riloha; Basilio Valladares; Zaida Herrador
Journal:  PLoS One       Date:  2017-05-03       Impact factor: 3.240

Review 5.  Perspectives on aetiology, pathophysiology and management of shock in African children.

Authors:  Julius Nteziyaremye; George Paasi; Kathy Burgoine; Jaffer Sadiq Balyejjusa; Crispus Tegu; Peter Olupot-Olupot
Journal:  Afr J Emerg Med       Date:  2017-11-21

6.  Effect of health seeking behaviour of caregivers on severe malaria outcome in under-fives seen in a tertiary health institution in Nigeria.

Authors:  Damian U Nwaneri; Ayebo E Sadoh
Journal:  Ghana Med J       Date:  2020-09

7.  Evaluation of the diagnostic accuracy and cost of different methods for the assessment of severe  anaemia in hospitalised children in Eastern Uganda.

Authors:  Peter Olupot-Olupot; Natalie Prevatt; Charles Engoru; Julius Nteziyaremye; Denis Amorut; Martin Chebet; Tonny Senyondo; Paul Ongodia; Carolyne M Ndila; Thomas N Williams; Kathryn Maitland
Journal:  Wellcome Open Res       Date:  2019-03-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.